1 Primary afferent neurones releasing the vasodilator, calcitonin gene-related peptide, mediate the gastric hyperaemic response to acid back-diffusion. The tachykinins neurokinin A (NKA) and substance P (SP) are located in the same neurones and are co-released with calcitonin gene-related peptide. In this study we investigated the effect and possible role of tachykinins in the acid-evoked gastric vasodilatation in urethane-anaesthetized rats. 2 Gastric acid back-diffusion, induced by perfusing the stomach with 15% ethanol in the presence of 0.05 M HCl, increased gastric mucosal blood flow by 60-90%, as determined by the hydrogen clearance technique. NKA and SP (0.14-3.78 nmol min-' kg-', infused intra-aortically) inhibited the gastric mucosal hyperaemic response to acid back-diffusion in a dose-dependent manner, an effect that was accompanied by aggravation of ethanol/acid-induced macroscopic haemorrhagic lesions. 3 The inhibitory effect of NKA (1.26 nmol min-' kg-') on the acid-induced gastric mucosal vasodilatation was prevented by the tachykinin NK2 receptor antagonist, MEN 10,627 (200 nmol kg-') but left unaltered by the NK, receptor antagonist, SR 140,333 (300 nmol kg-') and the mast-cell stabilizer, ketotifen (4.6 yimol kg-'). 4 Under basal conditions, with 0.05 M HCl being perfused through the stomach, NKA (1.26 nmol min-' kg-') reduced gastric mucosal blood flow by about 25%, an effect that was abolished by SR 140,333 but not MEN 10,627 or ketotifen. 5 SR 140,333, MEN 10,627 or ketotifen had no significant effect on basal gastric mucosal blood flow nor did they modify the gastric mucosal hyperaemic reaction to acid back-diffusion. 6 The effect of NKA (1.26 nmol min-' kg-') in causing vasoconstriction and inhibiting the vasodilator response to acid back-diffusion was also seen when blood flow in the left gastric artery was measured with the ultrasonic transit time shift technique. 7 Arginine vasopressin (AVP, 0.1 nmol min-' kg-') induced gastric mucosal vasoconstriction under basal conditions but was unable to inhibit the dilator response to acid back-diffusion. 8 These data show that NKA has two fundamentally different effects on the gastric circulation. Firstly, NKA reduces gastric blood flow by activation of NK1 receptors. Secondly, NKA inhibits the gastric hyperaemic response to acid back-diffusion through an NK2 receptor-mediated mechanism. These two tachykinin effects appear to take place independently of each other since they are mediated by different receptors. This concept is further supported by the inability of AVP to mimic tachykinin inhibition of the gastric vasodilator response to acid back-diffusion.
Introduction
Acid back-diffusion through a damaged gastric mucosal barrier causes a marked increase in blood flow through the gastric mucosa (Whittle, 1977; and large extramural arteries supplying the stomach such as the left gastric artery . This hyperaemia which reduces acid injury to the mucosa appears to be brought about by perivascular fibres of extrinsic primary afferent neurones Raybould et al., 1992) . Calcitonin generelated peptide (CGRP) is supposed to be the prime mediator since it is localized in and released from primary afferent neurones in the stomach (Sternini et al., 1987; Green & Dockray, 1988; Holzer et al., 1990) , since it is a potent vasodilator in the gastric microcirculation Holzer et al., 1993) and since CGRP receptor blockade inhibits the gastric vasodilator response to acid back-diffusion (Li et al., 1992; Holzer et al., 1994) .
The tachykinins substance P (SP) and neurokinin A (NKA) are likewise abundantly present in primary afferent neurones Author for correspondence. of the stomach (Green & Dockray, 1988) and co-released with CGRP upon nerve stimulation (Kwok & McIntosh, 1990) . In the skin, SP plays multiple roles in neurogenic inflammation (Brain, 1996) , causing plasma protein extravasation (Lembeck & Holzer, 1979) through activation of NK1 receptors (Lembeck et al., 1992) and reducing CGRP-induced vasodilatation via release of mast cell proteases (Brain & Williams, 1988) . The significance of tachykinins in the gastric vasculature which expresses receptors for these peptides (Mantyh et al., 1988 ) is less well studied. Unlike CGRP, SP and NKA fail to increase blood flow in the rat gastric mucosa . On the contrary, SP has been found to reduce the hyperaemia caused by electrical stimulation of the vagus nerve (Yokotani & Fujiwara, 1985) or capsaicin-evoked stimulation of afferent neurones (Gr0nbech & Lacy, 1994) . SP has furthermore been shown to aggravate ethanol-induced damage of the rat gastric mucosa (Karmeli et al., 1991) whereas NKA and NK2 receptor-selective analogues protect the gastric mucosa from ethanol injury (Evangelista et al., 1989; Stroff et al., 1996) .
While these data suggest that tachykinins are of relevance for the regulation of gastric circulation and mucosal integrity, Brifish Journal of Pharmacology (1996 Pharmacology ( ) 119, 1525 Pharmacology ( -1532 A. Heinemann et a! Tachykinins and gastric blood flow little is known about the precise effects of tachykinins on the gastric microcirculation, their possible implication in the acidevoked gastric hyperaemia and the nature of the tachykinin receptors in the vascular system of the stomach. The present study was designed, therefore, to re-examine the effects of tachykinins on basal blood flow in the rat gastric mucosa, to study their influence on the neurogenic vasodilator response to gastric acid back-diffusion and acid-induced mucosal injury, to characterize the pertinent tachykinin receptors with receptorselective antagonists, and to test for a possible implication of endogenous tachykinins in the control of gastric circulation.
Methods

Surgical procedure
All experiments in this study were approved by the Federal Ministry of Science and Research of the Republic of Austria. Female Sprague-Dawley rats, weighing 180 -220 g, were fasted for 20 h but were allowed free access to water. After the induction of anaesthesia with urethane (1.5 g kg-'s.c.) the rats were placed on a heated table, to maintain rectal temperature at 37 'C, and fitted with a tracheal cannula, to facilitate spontaneous respiration and to allow for the administration of hydrogen. An arterial cannula, inserted through the left carotid artery, was advanced into the descending aorta and connected to a pressure transducer (ISOTEC; HSE, March-Hugstetten, Germany). The amplified signal from the pressure transducer was fed into a personal computer via an analog-digital converter. Mean arterial pressure (MAP) and heart rate (HR) were calculated on-line. The arterial cannula was also used for continuous infusion of saline (1.5 ml h-'), to avoid dehydration, and for the administration of drugs, either as bolus or infusion (15 Ml min-'). The infusion of fluid did not interfere with the measurement of MAP. The stomach was exposed by a midline laparotomy and fitted with an inflow cannula placed in the forestomach and an outflow cannula inserted through the pylorus . The experimental media (kept at room temperature) were perfused through the stomach at a rate of 0.7 -0.8 ml min-' throughout the experiment.
Blood flow measurements
Gastric mucosal blood flow was measured by the hydrogen clearance technique. The washout of hydrogen gas was estimated by a needle-type platinum electrode inserted from the serosa into the basal portion of the gastric corpus mucosa and positioned at the submucosal border of the muscularis mucosae . Determination of blood flow was discontinuous, as the experimental protocol involved alternating 15-min periods of saturation, and desaturation, of the tissue with hydrogen. The current representing the actual hydrogen concentration at the site of the electrode was amplified, digitized and recorded on a personal computer. The washout curve was then fitted to a monoexponential curve, the power of which was used to calculate the average gastric mucosal blood flow (ml min-' [100 g]-') during the 15-min periods of desaturation (Livingston et al., 1989) .
Blood flow in the left gastric artery (LGA) was determined with the ultrasonic transit time shift technique (Barnes et al., 1983; Burton & Gorewit, 1984) by the use of a small animal flowmeter (model T106; Transonic, Ithaca, New York, U.S.A.) and a 1-mm ultrasonic flow probe (model 1RB; Transonic). The flow probe has been developed for measurements in small vessels and repeatedly used and validated in different arteries of the rat (Myers & Hernandez, 1992; Holzer et al., 1993; D'Almeida et al., 1995) . The LGA was isolated from the adjacent tissue over a segment of 3 mm close to its entry into the stomach. The flow probe was put around the artery and held in place by a micromanipulator.
The blood flow values, in ml min-', were likewise digitized and recorded on the computer.
To account for alterations of MAP which occurred due to the administration of drugs, vascular conductance in the gastric mucosa (GMVC) or LGA (LGVC) was calculated as blood flow divided by MAP. Effects on gastric haemodynamics were expressed as % changes of vascular conductance relative to baseline values (100%).
Macroscopic lesions
At the end of each experiment the stomach was excised and opened along the greater curvature. Macroscopic haemorrhagic lesions were quantified by computerized image analysis (MCID M4; Imaging Research, St. Catharines, Ontario, Canada) and expressed as % of the area of the glandular mucosa.
Study groups
Five studies were performed. The first study investigated the effects of NKA and SP, infused intra-aortically at different rates (0.14-3.78 nmol min-' kg-'), on the gastric mucosal hyperaemic response to acid back-diffusion which was induced by disrupting the mucosal barrier with 15% ethanol in the presence of 0.05 M HCL. The second study assessed the mechanisms and receptors behind the haemodynamic effects of NKA in the gastric mucosa. For this purpose the effect of NKA (1.26 nmol min-' kg-') on basal blood flow and the acid-evoked hyperaemia was studied in rats pretreated with either vehicle (2 x 1 ml kg-'), the NKI receptor antagonist, SR 140,333 (2 x 150 nmol kg-'), the NK2 receptor antagonist, MEN 10,627 (2 x 100 nmol kg-') or the mast-cell stabilizer, ketotifen (2 x 2.3 imol kg-'). The dose of 1.26 nmol min-' kg-I of NKA was chosen, since it had proved to be submaximally effective in the first study. The same dose of NKA (1.26 nmol min-' kg-') was used in study 3 to assess the peptide's effects on basal blood flow and the acid-induced hyperaemia in the LGA. Study 4 addressed the question whether vasoconstriction induced by arginine vasopressin (AVP; 0.1 nmol min-' kg-') would also inhibit the acidevoked gastric mucosal vasodilatation. The dose of AVP was selected in preliminary experiments such that the AVP-induced gastric mucosal vasoconstriction was of similar magnitude to that induced by NKA in study 2. Study S was performed to probe for an implication of endogenous tachykinins and mast cell mediators in the gastric mucosal hyperaemia due to acid back-diffusion. To this end the vasodilator response to intraluminal ethanol/acid was determined in rats that had been pretreated with vehicle (2 x 1 ml kg-'), SR 140, 333 (2x 150 nmol kg-'), MEN 10,627 (2x 100 nmol kg-') or ketotifen (2 x 2.3 ,umol kg-').
Experimental protocol
After the preparation had been completed the animals were allowed to equilibrate for 30 min. For 10, 627 (2 x 100 nmol kg-') or ketotifen (2 x 2.3 umol kg-') was administered intra-aortically at two doses, the first one being injected at the beginning of the second saturation/desaturation period while the second dose 1526 A. Heinemann et al Tachykinins and gastric blood flow was given at the beginning of the third saturation/desaturation period. According to this protocol the first desaturation period always measured basal gastric mucosal blood flow, the second period accounted for basal gastric mucosal blood flow in the presence of vehicle, tachykinin antagonists or ketotifen whereas the third desaturation period determined the haemodynamic effects of NKA, SP or AVP on basal blood flow or on the hyperaemia caused by acid back-diffusion.
A similar protocol was adhered to when the haemodynamic effects of NKA were evaluated in the LGA. Basal blood flow in the LGA (perfusion of the stomach with 0.05 M HCl) was recorded during the 15 min period immediately before the intraaortic infusion of NKA was started. The effects of NKA in the LGA on basal blood flow and on the hyperaemic response to acid back-diffusion (gastric perfusion with 15% ethanol in 0.05 M HCl) were determined from the average blood flow measured during the period of 15 -30 min after the start of the peptide's infusion and induction of acid back-diffusion, respectively.
Substances
The saline solution used here was 0.15 M NaCl. Urethane (Fluka; Buchs, Switzerland) was dissolved in water at a concentration of 25% (wt/wt). AVP (Bachem; Bubendorf, Switzerland), SP and NKA (Peptide Institute; Osaka, Japan) were dissolved in 0.1 M acetic acid to give stock solutions of 1 mM. Dilutions ready for infusion were made with saline containing 2% (wt./wt.) bovine serum albumin (Sigma; Vienna, Austria). Stock solutions (10-15 mM) of SR 140,333 
Results
Effects of neurokinin A (NKA) and substance P (SP) Intra-aortic infusion of NKA or SP (0.14-3.78 nmol min-' kg-') led, in most cases, to a transient fall of MAP, which at the higher doses of the peptides amounted to 20-30 mmHg (Figure 1 ). This hypotensive effect was not further evaluated, since it was not observed in all study groups and had vanished when blood flow measurements with the hydrogen clearance technique were begun 15 LGBF A 5 min (4) and the end (t) of a 20min intra-aortic infusion of neurokinin A (1.26nmol min-' kg-). (Tables 1 -3) and were, therefore, not further analysed. Disruption of the gastric mucosal barrier with 15% ethanol in the presence of 0.05 M HCl, which is known to cause acid back-diffusion into the mucosa , led to a 60-90% increase in gastric mucosal blood flow (Tables 1, 4 and 5) and a 170% enhancement of blood flow in the LGA (Table 2 ). The changes in GMVC and LGVC were similar as gastric hyperaemia took place in the absence of any alteration of MAP (Tables 2 and 5 ; Figures 2-4). HR was also unaffected (Table 1 , 2, 4 and 5). Intra-aortic infusion of NKA and SP (0.14-3.78 nmol min' kg-') dose-dependently reduced the gastric mucosal dilator response to acid back-diffusion, NKA being at least three times more potent than SP (Table 1, Figure 2 ). At the higher doses of NKA (1.26-3.78 nmol min-' kg-) the ethanol/acid-induced vasodilatation was even reversed to vasoconstriction. The inhibition of the vasodilator response to acid back-diffusion by NKA (1.26 nmol min' kg-') was also seen when blood flow was measured in the LGA (Table 2) . Concomitantly with the suppression of the ethanol/acid-evoked hyperaemia the area of the macroscopically damaged mucosa was increased by NKA and SP (Figure 2 ). These pro-ulcerogenic effects became manifest with the highest tachykinin doses only, NKA being again more potent than SP. Under basal conditions, with 0.05 M HCl being perfused through the stomach, NKA (1.26 nmol min' kg-') reduced both blood flow and vascular conductance in the gastric mucosa (Table 3) and LGA (Table 2, Figure 1 ) by about 30%. As can be seen in Figure 1 , the vasoconstrictor effect of NKA was rapid in onset, sustained, and quickly waned after termination of the peptide's infusion. Under these conditions, no macroscopically visible lesions in the gastric mucosa were observed after intra-aortic infusion of vehicle or NKA (1.26 nmol min-' kg -).
Effects of arginine vasopressin (A VP)
Intra-aortic infusion of AVP (0.1 nmol min' kg-') caused sustained hypertension without significantly altering HR ( Table examine whether or not the tachykinin antagonists and ketotifen would prevent NKA from aggravating mucosal injury. Unlike the anti-vasodilator action, the effect of NKA (1.26 nmol min-' kg-) in reducing basal gastric mucosal blood flow was prevented by SR 140,333 (2 x 150 nmol kg-') whereas MEN 10,627 (2 x 100 nmol kg-') and ketotifen (2 x 2.3 ymol kg ') were ineffective (Table 3) .
al., 1994). In order to accommodate the divergent data in a single hypothesis we propose that NKA and SP exert two independent and opposing effects on gastric mucosal homeostasis: a blood flow-independent protective action and a proulcerogenic action due to inhibition of the hyperaemic response to acid back-diffusion. Evidence for this conjecture comes from the observation that SP and NKA worsened mu-
Discussion
The present data demonstrate that NKA potently modulates the gastric circulation under resting conditions and during acid challenge of the mucosa. Of particular novelty was the finding that the hyperaemic response to acid back-diffusion, induced by perfusing the stomach with 15% ethanol in 0.05 M HCl , was dose-dependently depressed by SP and NKA. The observation that NKA inhibited the ethanol/ acid-evoked hyperaemia in the LGA to a smaller extent than that in the gastric mucosa could be indicative of a primary action in the mucosal microcirculation while the muscular microcirculation is little affected. The anti-vasodilator effect of NKA and SP was accompanied by aggravation of the ethanol/ acid-induced damage to the mucosa, which attests to the essential role of hyperaemia in protecting the gastric mucosa from influxing acid Guttu et al., 1994) . The ability of SP to exacerbate acid back-diffusion injury is consistent with the action of this peptide in worsening ethanol injury (Karmeli et al., 1991) . The deleterious effect of NKA seen here, however, is at variance with the reported ability of NKA and NK2 receptor-selective agonists to protect the gastric mucosa from ethanol damage (Evangelista et al., 1989; Stroff et al., 1996) at doses that are in the range of, or beyond, those used in our experiments. The assumption that the hyperaemic reaction to ethanol/acid perfusion is blunted because tachykinins reduce acid back-diffusion by virtue of their gastroprotective action is invalidated by the pro-ulcerogenic effect of NKA and SP under conditions of acid back-diffusion.
The discrepancy between our data and those of other studies is most probably related to the profoundly different nature of the experimental models and the associated microcirculatory conditions. While ethanol/acid challenge provokes vasidilatation, and the ensuing hyperaemia is an important factor in limiting acid back-diffusion injury, blood flow does not rise in response to challenge with ethanol alone and in fact decreases after exposure to high concentrations of ethanol because of venular constriction (Yonei & Guth, 1988) . The protective effect of NKA against ethanol injury is associated with a decrease, not increase, in blood flow (Stroff et al., 1996) , which shows that hyperaemia is not a prerequisite for protection from ethanol injury whereas suppression of the acid/ethanol-evoked hyperaemia is invariably followed by aggravation of damage Li et al., 1992; Quintero et al., 1992; Raybould et al., 1992; Petho et Tachykinins and gastric blood flow cosal injury only when the ethanol/acid-induced vasodilatation was totally suppressed. According to our hypothesis this result means that the injurious action of a partially reduced hyperaemic reaction is balanced by the blood flow-independent protective influence of tachykinins. This beneficial effect, though, is completely overridden when the protective hyperaemia due to acid back-diffusion is abolished by high tachykinin doses.
SP was less potent than NKA in inhibiting the gastric mucosal hyperaemia and in enhancing the formation of mucosal lesions caused by acid back-diffusion, which suggests that these tachykinin effects may not be mediated by NK1 receptors.
Indeed, the NKI receptor antagonist, SR 140,333 (2 x 150 nmol kg-') failed to alter the ability of NKA to prevent the gastric hyperaemia due to acid back-diffusion whereas pretreatment of the rats with the NK2 receptor antagonist, MEN 10,627 (2 x 100 nmol kg-') restored the vasodilator response to normal. Since the antagonist doses used here have been described as effective and receptor-selective (Emonds-Alt et al., 1993; Maggi et al., 1994) it is concluded that the antivasodilator effect of NKA is mediated by NK2 receptors. Because of the higher potency of NKA in our model compared to that of SP, only the action of NKA was further analysed by pharmacological means.
SP has been reported to inhibit the CGRP-induced vasodilatation in the rat skin and the capsaicin-induced mucosal hyperaemia in the rat stomach by releasing mast cell proteases which readily inactivate CGRP by cleavage (Brain & Williams, 1988; Gr0nbech & Lacy, 1994) . Since the gastric vasodilatation in response to acid back-diffusion is likewise brought about by capsaicin-sensitive afferent neurones Raybould et al., 1992) that utilize CGRP as their major vasodilator mediator (Li et al., 1992; Holzer et al., 1994) it was deemed worth examining whether factors liberated from mast cells are responsible for the inhibitory effect of NKA on the ethanol/acid-induced gastric vasodilatation. However, pretreatment of rats with a dose of ketotifen (2 x 2.3 jmol kg-') that effectively protects gastric mast cells from degranulation by SP (Gr0nbech & Lacy, 1994) did not reverse the inhibition by NKA of the gastric mucosal vasodilator response to acid back-diffusion. Thus, the anti-vasodilator action of NKA is unlikely to involve degranulation of mast cells.
Another finding of the current study was that NKA attenuated basal blood flow through the gastric mucosa and LGA. Previous studies have reported that NKA, at doses lower than those used here, and SP do not alter resting gastric mucosal blood flow (Yokotani & Fujiwara, 1985; Gr0nbech & Lacy, 1994) . The presently observed vasoconstrictor effect of NKA (1.26 nmol min-' kg-') is confirmed by the ability of NKA4_1) (130 nmol kg-') to reduce gastric mucosal blood flow (Stroff et al., 1996) . Like the suppression of the ethanol/acid-evoked hyperaemia, the NKA-induced attenuation of basal blood flow was not altered by ketotifen, which indicates that mast cell-derived vasoconstrictors such as platelet-activating factor are not involved. The possibility that catecholamines, which mediate tachykinin-evoked tachycardia (Hancock & Lindsay, 1995) , play a role in the vasoconstrictor mechanism deserves further study. It is important to realize, though, that the vasoconstrictor action of NKA does not seem to be responsible for inhibition of the vasodilator response to acid back-diffusion. This conclusion is supported by two independent sets of data.
Firstly, the tachykinin receptors underlying the vasoconstrictor and anti-vasodilator actions of NKA are different. Thus, pretreatment of rats with SR 140,333 suppressed the ability of NKA to reduce resting mucosal blood flow whereas MEN 10,627 was ineffective. It follows that, unlike the peptide's anti-vasodilator effect which is mediated by NK2 receptors, the vasoconstrictor effect is brought about by NKI receptors. NKI receptor-induced constrictor responses have also been noted in the rat mesenteric veins (Claing et al., 1992) and in the rabbit intrapulmonary arteries (Shirahase et al., 1995) .
Secondly, vasoconstriction per se was shown to be unable to suppress the hyperaemic response to acid back-diffusion. This inference is based on the observation that AVP, at a dose (0.1 nmol min-' kg-') that constricted the gastric mucosal vasculature to a similar extent to an effective anti-vasodilator dose of NKA (1.26 nmol min-' kg-'), failed to blunt significantly the ethanol/acid-evoked hyperaemia. To overcome acid-evoked hyperaemia, a much higher degree of AVPinduced vasoconstriction, corresponding to the vasodilator response induced by acid back-diffusion, would be required. These findings corroborate the conjecture that NKA-evoked vasoconstriction and inhibition of the vasodilator reaction to acid back-diffusion take place independently of each other. The reversal of the ethanol/acid-induced vasodilatation to vasoconstriction, which was seen with high doses of NKA (1.26-3.78 nmol min-' kg-'), is likely to reflect a combination of the peptide's two independent haemodynamic actions. The observation that this NKI/NK2 receptor-mediated action was completely reversed by a NK2 receptor antagonist is in keeping with our notion that vasoconstriction per se, be it induced by NKA or AVP, does not interfere with the acidevoked hyperaemia. A comparison with other vasoconstrictor peptides discloses that NKA is roughly as potent as angiotensin II (Wachter et al., 1996) but at least one order of magnitude less active than AVP in constricting the gastric mucosal vasculature.
Despite the demonstration of potent modulator effects of exogenous NKA in the gastric circulation, the present study failed to provide evidence that endogenously released tachykinins have a bearing on gastric blood flow regulation. Neither resting blood flow nor the mucosal vasodilator response to acid back-diffusion was significantly altered by the tachykinin receptor antagonists, SR 140,333 and MEN 10,627. The lack of effect of these antagonists on resting gastric mucosal blood flow might have been foreseen since perivascular afferent neurones, a major source of tachykinins in the stomach (Green & Dockray, 1988) , seem to be inactive under basal conditions and antagonism of the co-released vasodilator messenger CGRP does not affect resting gastric blood flow (Li et al., 1992; Holzer et al., 1994) . However, NKI and NK2 receptor blockade also failed to affect significantly (enhance) the gastric hyperaemic response to acid back-diffusion, a condition that effectively stimulates gastric afferent neurones. It can hence be inferred that endogenous tachykinins, should they be released, do not appreciably modulate the ethanol/acid-evoked vasodilatation although it should be mentioned in passing that the NK2 receptor antagonist, MEN 10,627, caused a slight, insignificant enhancement of the hyperaemia due to acid backdiffusion (Table 5 ). Further pertinent in this respect is that certain forms of chronic inflammation cause upregulation of tachykinins (Koch et al., 1987; Swain et al., 1992; Bost, 1995) and tachykinin receptors (Mantyh et al., 1988; 1995) in the gastrointestinal tract. It is conceivable, therefore, that in the chronically inflamed gastric mucosa, endogenous tachykinins may gain pathogenic significance as inhibitors of protective mucosal hyperaemia.
In conclusion, the current data demonstrate that tachykinins, particularly NKA, inhibit the protective gastric hyperaemia in response to acid back-diffusion through an NK2 receptor-mediated mechanism. In addition, NKA constricts the gastric vasculature under resting conditions, an effect that involves NK, receptors and is unrelated to the peptide's antivasodilator activity. The relevance of these tachykinin actions for gastric circulatory control remains to be elucidated. This work was supported by the Austrian Science Foundation (FWF, grants P9473-MED and P1 1834-MED). The authors are grateful to Dr C.A. Maggi for providing a sample of MEN 10,627, to Dr X. Emonds-Alt for providing a sample of SR 140,333 and to Mr Wolfgang Schluet for organizational help.
